-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Many respiratory infections, such as the flu or COVID-19, can place significant stress on cells and organs, leading to acute respiratory distress syndrome (ARDS), which itself can ultimately lead to death in elderly or sensitive individuals
Professor Johan Auwerx, from EPFL's School of Life Sciences, said: "New therapeutic strategies to address ARDS, rather than combating the source of infection, could induce tolerance to inflammatory challenges by enhancing the host organism's natural adaptive stress response
In a new study, EPFL's Adrienne Mottis and her colleagues show that one such strategy can exploit a biological phenomenon known as "mitochondrial hypoxemia
Mitochondria are the cell's main organelle for energy harvesting and are therefore constantly monitored by the cell's "surveillance" system
"Therefore, mild mitochondrial stress is beneficial for the cell and the organism as a whole, as the positive effects of these stress responses can overcome the negative effects of the initial stressor," said Mottis, who led the study
Because mitochondria evolved from bacteria, they are sensitive to antibiotics
The team of scientists screened 52 tetracyclines and selected new molecules, such as 9-tert-butyldoxycycline (9-TB), which are highly effective in triggering the mitochondrial hypostimulant effect even at low doses, while simultaneously There are no antibiotic side effects -- that is, they don't interfere with the host's microbiome
Auwerx added: "Most importantly, our study shows that 9-TB-triggered mitochondrial responses activate the ATF4 signaling pathway, a well-described response to multiple cellular stressors that also mobilizes innate immunity , the so-called type I interferon response
The study shows that 9-TB can induce tolerance to influenza infection in mice by reducing the degree of inflammation and tissue damage without affecting the mice's microbiota
Tetracycline-induced mitohormesis mediates disease tolerance against influenza